BRIEF published on 05/05/2026 at 17:05, 6 months ago Medacta Group SA clôture une assemblée générale annuelle réussie Réélection Du Conseil D'administration Rapports Financiers Participation Des Actionnaires Approbation Des Dividendes Assemblée Générale Annuelle De Medacta
PRESS RELEASE published on 05/05/2026 at 17:00, 6 months ago Medacta announces the results of today's Annual General Meeting Medacta Group SA announced the results of the Annual General Meeting, with approval of all proposals, CHF 21.9 million distribution, and re-election of Board members Board Of Directors Annual General Meeting Dividend Distribution Medacta Group SA AGM Results
BRIEF published on 04/01/2026 at 06:05, 7 months 4 days ago Medacta Joins International Dino-Revival Project Biotechnology Medacta Research Project Dinosaurs Tyrannosaurus Rex
BRIEF published on 04/01/2026 at 06:05, 7 months 4 days ago Medacta rejoint le projet international de renaissance des dinosaures Biotechnologie Medacta Projet De Recherche Dinosaures Tyrannosaure Rex
PRESS RELEASE published on 04/01/2026 at 06:00, 7 months 4 days ago Medacta selected as partner for groundbreaking international research project Medacta selected to join international research project aiming to recreate dinosaurs from DNA samples, collaborating with leading scientists for specialized orthopaedic hip prosthesis development Scientific Collaboration Medacta Dinosaur Research DNA Samples Orthopaedic Hip Prosthesis
BRIEF published on 03/13/2026 at 07:05, 7 months 23 days ago Medacta Group Announces Record 2025 Results and Positive Outlook Revenue Growth Market Expansion Innovation Strategy Medacta Group 2025 Financial Results
BRIEF published on 03/13/2026 at 07:05, 7 months 23 days ago Medacta Group annonce des résultats records pour 2025 et des perspectives positives. Croissance Des Revenus Stratégie D'innovation Groupe Medacta Expansion Du Marché Résultats Financiers 2025
PRESS RELEASE published on 03/13/2026 at 07:00, 7 months 23 days ago Medacta Group SA: Medacta Group reports record results in Full Year 2025 and upgrades mid-term guidance Medacta Group reports record results for FY 2025 with revenue of Euro 683.8 million and upgrades mid-term guidance, focusing on sustainable innovation and global growth Innovation Revenue Growth Record Results Mid-term Guidance Medacta Group
BRIEF published on 02/03/2026 at 07:05, 9 months 2 days ago Medacta Group Reports Remarkable 18.5% Revenue Growth in 2025 Revenue Growth Regional Performance Medacta Group Medical Innovations 2025 Financials
BRIEF published on 02/03/2026 at 07:05, 9 months 2 days ago Le groupe Medacta annonce une croissance remarquable de son chiffre d'affaires de 18,5 % en 2025 Croissance Des Revenus Performance Régionale Groupe Medacta Innovations Médicales Données Financières 2025
Published on 11/06/2026 at 00:53, 1 hour 30 minutes ago Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 1 hour 38 minutes ago Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/05/2026 at 23:55, 2 hours 28 minutes ago Santé Canada autorise deux vaccins à ARNm de Moderna : un vaccin contre la grippe et un vaccin combiné contre la grippe et la COVID-19
Published on 11/05/2026 at 23:20, 3 hours 3 minutes ago Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines
Published on 11/06/2026 at 00:05, 2 hours 18 minutes ago RBI: Announcement of the result of the voluntary public tender offer for all Addiko shares following expiration of the grace period
Published on 11/05/2026 at 22:05, 4 hours 18 minutes ago Quantinuum Reports Third Quarter 2026 Results and Raises Full-Year Revenue Outlook
Published on 11/05/2026 at 20:38, 5 hours 45 minutes ago freenet uses funds from Ceconomy sale for waipu.tv acquisition and share buyback
Published on 11/05/2026 at 20:37, 5 hours 46 minutes ago EQS-Adhoc: freenet AG decides on share buyback programme for up to EUR 75 million
Published on 11/05/2026 at 19:45, 6 hours 37 minutes ago Stabilus SE fulfills forecast for fiscal 2026 and adjusts 2030 medium-term targets
Published on 11/05/2026 at 18:21, 8 hours 1 minute ago Total number of voting rights and shares making up the share capital at October 31, 2026
